Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 3, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

Wilson's disease in Taiwan.

Nai-Shin Chu1, Chin-Chang Huang

  • 1Department of Neurology, Chang Gung Memorial Hospital and College of Medicine, Chang Gung University, Lin-kou, Taiwan. chu060@cgmh.org.tw

Acta Neurologica Taiwanica
|August 9, 2008
PubMed
Summary

Wilson's disease research in Taiwan began in the 1960s, focusing on d-penicillamine treatment and its effects on copper levels and patient outcomes. Later studies explored neurological involvement and hepatitis B co-infection impacts.

Related Concept Videos

Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A clinically feasible framework to estimate tau pathology and clinical-biological discordance in the Alzheimer's disease spectrum.

Alzheimer's research & therapy·2026
Same author

Taiwan Clinical Practice Guidelines for Myasthenia Gravis.

Acta neurologica Taiwanica·2026
Same author

ADAS-Cog11 performance as a surrogate of tau PET burden in an Asian Alzheimer's disease cohort.

Journal of Alzheimer's disease : JAD·2026
Same author

Visual interpretation of [<sup>18</sup>F]Florzolotau Tau-PET imaging for differentiating alzheimer's disease and progressive supranuclear palsy.

European journal of nuclear medicine and molecular imaging·2025
Same author

Epidemiology and diagnostic challenges in neuromyelitis optica spectrum disorder in Taiwan: a hospital-based surveillance accompanied by a nationwide study.

Brain communications·2025
Same author

The Taiwan-ADNI workflow toward integrating plasma p-tau217 into prediction models for the risk of Alzheimer's disease and tau burden.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Area of Science:

  • Medical Research
  • Hepatology
  • Neurology

Background:

  • Wilson's disease (WD) research in Taiwan spans over four decades, initiated in the 1960s.
  • Early studies were conducted at the U.S. Naval Medical Research Unit No. 2 (NAMRU-2).
  • D-penicillamine was introduced to Taiwan through NAMRU-2 as a key therapeutic agent.

Purpose of the Study:

  • To review the historical progression of Wilson's disease research in Taiwan.
  • To highlight key findings regarding clinical manifestations and treatment efficacy.
  • To discuss advancements in understanding neurological involvement and co-morbidities.

Main Methods:

  • Historical review of published studies and research conducted since the 1960s.
  • Analysis of clinical data, including copper concentrations and therapeutic responses.
  • Inclusion of studies investigating central nervous system (CNS) involvement and hepatitis B co-infection.

Main Results:

  • D-penicillamine demonstrated efficacy in reducing copper levels and improving prognosis.
  • Evoked potentials were utilized to assess the extent of CNS involvement.
  • Hepatitis B infection was identified as a factor influencing WD clinical presentation and prognosis.

Conclusions:

  • Wilson's disease research in Taiwan has evolved significantly since the 1960s.
  • Understanding of WD pathogenesis, clinical spectrum, and treatment has advanced.
  • Further research is warranted to address specific challenges, such as co-infections and neurological manifestations.

More Related Videos

Standard Operating Procedure for Lyssavirus Surveillance of the Bat Population in Taiwan
07:55

Standard Operating Procedure for Lyssavirus Surveillance of the Bat Population in Taiwan

Published on: August 27, 2019

Related Experiment Videos

Last Updated: Jul 3, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

Standard Operating Procedure for Lyssavirus Surveillance of the Bat Population in Taiwan
07:55

Standard Operating Procedure for Lyssavirus Surveillance of the Bat Population in Taiwan

Published on: August 27, 2019